Dr. Miguel Martin, born in 1954, is currently Head of the Medical Oncology Service at the Hospital General Universitario Gregorio Marañón in Madrid (Spain). He is also a Professor of Medical Oncology at the Complutense University of Madrid.
Dr. Martin studied Medicine at the University of Valladolid (Spain) between 1971 and 1977. From 1980 to 1983 he did his Residence in Internal Medicine/Medical Oncology, at the Hospital Universitario San Carlos in Madrid (Spain). In 1984, he got the Spanish Certification on Medical Oncology and in 1985, a Ph degree. In 1989, he obtained the European Certification on Medical Oncology.
From 1983 to 1991, Dr Martin worked as Attending Physician in the Medical Oncology Department, at the University Hospital in Madrid (Spain). From 1991 to 1992, he visited the Fred Hutchinson Cancer Research Center and the University of Washington Medical Center in Seattle (USA). In 1994, he was appointed as Chief of Breast Cancer Section in the Medical Oncology Department, at the University Hospital in Madrid (Spain).
Dr. Martin is a founder member of CIRG (Cancer International Research Group) and serves as a member of the Board of Directors of CIRG (now named TRIO). He also is member of the Steering Committee of the TRIO Breast Cancer Working Group. Dr. Martin is a former member of the International Affairs Committee of ASCO (American Society of Clinical Oncology).
Dr. Martin is the first/corresponding author of more than 100 original articles in international journals, including New England Journal of Medicine, Journal of the National Cancer Institute, Journal of Clinical Oncology, Lancet Oncology, Annals of Oncology, Breast Cancer Research and Treatment, Seminars in Oncology, and others, mainly devoted to breast cancer, new drugs and supportive care. He has also co-authored other 120 articles in Spanish and international journals. He is an active member of the following Societies: ASCO, ESMO, American Society of Breast Diseases, EBMT, ABMT and MASCC.
Dr. Martin is the Chairman of GEICAM (Spanish Group for Breast Cancer Research), a cooperative network involving more than 170 Spanish institutions. GEICAM has performed more than 40 clinical trials involving more than 10.000 breast cancer women and is the reference group for breast cancer in Spain.